EMEA-000311-PIP03-11-M02

Key facts

Invented name
Stelara
Active substance
Ustekinumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0109/2017
PIP number
EMEA-000311-PIP03-11-M02
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic idiopathic arthritis (including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylarthritis and juvenile idiopathic arthritis)
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Janssen-Cilag International NV

E-mail: contact@janssen-emea.com
Tel.: +32 14602111

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating